EXPLORE CONNECTIONS
M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.